Abnormal glucose tolerance
1 paper1 finding
- Humans1
Associations
1Metabolic dysfunction-associated steatotic liver disease
upin humans1
1 study
Metabolic dysfunction-associated steatotic liver disease
upin humans1
Metabolic dysfunction-associated steatotic liver disease is associated with abnormal glucose tolerance in humans (47% vs 27%, p<0.01).
“abnormal glucose tolerance (47% vs 27%), both p<0.01.”
Humansin African immigrantsn = 610
ADA Scientific Sessions 2025 abstract13 Jun 2025
More on Metabolic dysfunction-associated steatotic liver disease
Trial sponsors
1 trialPhase 230 people
Latest
1 in 12 monthsJournal of Hypertension
Acute mental stress-induced adrenergic reactivity profiles predict distinct cardiometabolic risk trajectories over three years: the SABPA study
Cohort study of 227 peoplePopulations
ADA Scientific Sessions 2025 Abstract
Effects of Glucagon-Like Peptide 1 (GLP-1) Agonist Therapy on Islet Function in Adults with Pancreatic-Insufficient Cystic Fibrosis ( PI-CF) and Abnormal Glucose Tolerance (AGT)—Preliminary Results
Randomised trial in 11 peopleGLP-1 receptor agonists
ADA Scientific Sessions 2025 Abstract
Prevalence and Predictors of Metabolic Dysfunction–Associated Steatotic Liver Disease in African Immigrants
Cross-sectional study of 610 peopleMetabolic dysfunction-associated steatotic liver disease
ADA Scientific Sessions 2025 Abstract
Glucose-6-Phosphate Dehydrogenase Deficiency Masks the Diagnosis of Abnormal Glucose Tolerance by A1C—The Africans in America Study
Cohort study of 506 peopleImpaired glucose tolerance
ADA Scientific Sessions 2025 Abstract
Prevalence and Predictors of Glucose Intolerance after Gestational Diabetes Mellitus by 2013 WHO Criteria (IADPSG)
Cohort study of 575 peopleGestational diabetes mellitus
Brain, Behavior, and Immunity
Abnormal glucose tolerance, white blood cell count, and telomere length in newly diagnosed, antidepressant-naïve patients with depression
Case-control study of 70 peopleWhite blood cell count